Literature DB >> 3128465

Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension.

D Westaby1, A Gimson, P C Hayes, R Williams.   

Abstract

We have evaluated the haemodynamic effects of intravenous (iv) nitroglycerin (NG) and vasopressin (VP) alone and in combination, in 12 patients with cirrhosis and recent variceal haemorrhage (two to seven days). Nitroglycerin infusion alone (200 micrograms/min) produced a significant fall in portal pressure (WHVP-FHVP) (from 16.4 (0.6) to 13.3 (1.2) mmHg; p less than .001) associated with hypotension (mean arterial pressure from 95 (7) to 78 (9) mmHg; p less than 0.005). Vasopressin alone (0.4 IU/min) reduced portal pressure (20.7 (1.3) to 14.0 (1.3) mmHg; p less than 0.001), but there was considerable variation in the systemic haemodynamic changes with increased cardiac output in four of six patients. The combination of vasopressin and nitroglycerin corrected all systemic haemodynamic disturbances produced by either agent alone. This combination led, however, to a further reduction in portal pressure (from 13.7 (0.9) to 11.7 (0.7) mmHg p less than 0.01). These results show that: (1) intravenous nitroglycerin reduces portal pressure, and (2) the combination of nitroglycerin and vasopressin reverses systemic haemodynamic disturbances produced by either agent alone and leads to a further decrease in portal pressure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128465      PMCID: PMC1433609          DOI: 10.1136/gut.29.3.372

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  6 in total

1.  Controlled trial of vasopressin plus nitroglycerin vs. vasopressin alone in the treatment of bleeding esophageal varices.

Authors:  Y T Tsai; C S Lay; K H Lai; W W Ng; Y S Yeh; J Y Wang; T T Chiang; S D Lee; B N Chiang; K J Lo
Journal:  Hepatology       Date:  1986 May-Jun       Impact factor: 17.425

2.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

3.  Thermodilution cardiac output determination with a single flow-directed catheter.

Authors:  J S Forrester; W Ganz; G Diamond; T McHugh; D W Chonette; H J Swan
Journal:  Am Heart J       Date:  1972-03       Impact factor: 4.749

4.  Nitroglycerin improves the hemodynamic response to vasopressin in portal hypertension.

Authors:  R J Groszmann; D Kravetz; J Bosch; M Glickman; J Bruix; J Bredfeldt; H O Conn; J Rodes; E H Storer
Journal:  Hepatology       Date:  1982 Nov-Dec       Impact factor: 17.425

5.  The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model.

Authors:  R J Kroeger; R J Groszmann
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

6.  Vasopressin and splanchnic shunting. A quantitative comparison.

Authors:  J G Chandler
Journal:  Ann Surg       Date:  1982-05       Impact factor: 12.969

  6 in total
  6 in total

Review 1.  The management of an episode of variceal bleeding.

Authors:  A E Gimson; D Westaby
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

Review 2.  The use of vasopressin in the treatment of upper gastrointestinal haemorrhage.

Authors:  D L Stump; T C Hardin
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

3.  Chronic splanchnic hemodynamic effects of low-dose transdermal nitroglycerin versus low-dose transdermal nitroglycerin plus spironolactone in patients with cirrhosis.

Authors:  S Sugano; T Suzuki; M Nishio; H Makino; T Okajima
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

Review 4.  Acute management of bleeding oesophageal varices.

Authors:  A K Burroughs
Journal:  Drugs       Date:  1992       Impact factor: 9.546

5.  Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.

Authors:  N Hori; T Okanoue; Y Sawa; Y Itoh; T Mori; S Takami; K Kashima
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

6.  Effect and mechanism of action of isosorbide-5-mononitrate.

Authors:  P C Hayes; D Westaby; R Williams
Journal:  Gut       Date:  1988-06       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.